Alain Mange

Title: Alain Mange - Innovator in Radiosensitivity Determination

Introduction

Alain Mange is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medical research, particularly in the area of radiosensitivity. His innovative approach has the potential to impact how patients are treated in relation to radiation exposure.

Latest Patents

Alain Mange holds a patent for a method for determining radiosensitivity. This invention relates to an in vitro method for assessing the radiosensitivity of a subject. The process involves inducing an exogenous stress on a biological sample from the subject, followed by comparing the presence or level of specific compounds in the biological sample and a reference sample. This method also identifies at least one compound as a predictive biomarker for the radiosensitivity of a subject. Additionally, the invention includes a kit designed for the detection of these compounds, which can be utilized in the described method.

Career Highlights

Throughout his career, Alain Mange has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Montpellier and the Institut Régional du Cancer de Montpellier. His work in these organizations has allowed him to collaborate with leading professionals in the field of cancer research and treatment.

Collaborations

Alain has collaborated with notable colleagues, including David Azria and Jerome Lacombe. Their combined expertise has contributed to advancements in understanding radiosensitivity and improving patient outcomes.

Conclusion

Alain Mange's innovative work in determining radiosensitivity showcases his commitment to advancing medical research. His contributions have the potential to enhance treatment protocols for patients exposed to radiation.